Dr Shoaib is expert in the field of nicotine dependence with emphasis on cognitive measures associated with neuropsychiatric disorders. He has served as an executive Council member for the British Association for Psychopharmacology (BAP) and as Program Chair for the Society for Research on Nicotine and Tobacco in Europe (SRNT-E).

Collaboration: effects of 5-HT1A receptor ‘biased’ agonists on nicotine-induced cognitive deficits

gonistes 'biaisés' des récepteurs sérotoninergiques 5-HT1A sur les déficits cognitifs induits par la nicotine




Please enable the javascript to submit this form

Follow Neurolixis on: